Gene · 771
Papers1,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of S100A4, CA-12, CA-9, Annexin A1/A2, and Galectin-3 in Prostate Cancer: Diagnostic and Prognostic Implications. | Asian Pac J Cancer Prev | 2026 | 42808395 | PubTator, text mining | PubMed |
| Enthalpy-entropy compensation in inhibitor binding to carbonic anhydrase isozymes. | Biophys J | 2026 | 42802557 | PubTator, text mining | PubMed |
| Multiscale Transcriptomic and Molecular Modeling Analyses Suggest DCPMU-Associated Epithelial Remodeling and Tumor Microenvironment Perturbation in Prostate Cancer. | Curr Issues Mol Biol | 2026 | 42793291 | PubTator, text mining | PubMed |
| My Love Story With HIFs in the Disc: A Journey to the Humboldt Research Award. | JOR Spine | 2026 | 42694344 | PubTator, text mining | PubMed |
| Explainable Multi-Isoform QSAR, PubChem Concordance, and Applicability-Domain-Guided Prioritization of Selective Human Carbonic Anhydrase I, II, IX, and XII Inhibitors. | Pharmaceuticals (Basel) | 2026 | 42653817 | PubTator, text mining | PubMed |
| Human Nasal and Bronchial Epithelium in Cystic Fibrosis: Differences in Expression of Airway pH Regulatory Proteins. | Pediatr Pulmonol | 2026 | 42591023 | PubTator, text mining | PubMed |
| Clone-By-Clone Therapy Guidance in Luminal Breast Cancer Via Spatial Proteomics and Patient-Derived Tumoroid. | Mol Cell Proteomics | 2026 | 42586237 | PubTator, text mining | PubMed |
| Hedgehog Signaling Regulates Hypoxia-Associated Metabolic Adaptation in Myeloid Leukemia In Vitro Cell Models. | Int J Mol Sci | 2026 | 42511667 | PubTator, text mining | PubMed |
| 1-Aryl-6,7-Dimethoxy-3,4-Dihydroisoquinoline-2(1H)-Sulfonamides as hCA XII Selective Inhibitors: Experimental and Theoretical Studies to Interrogate the Isoform Selectivity. | ChemMedChem | 2026 | 42493249 | PubTator, text mining | PubMed |
| Carbonic anhydrase IX and XII. | Enzymes | 2026 | 42486548 | PubTator, text mining | PubMed |
| Amino-acids-mTORC1-driven DDA1 phosphorylation promotes DNA repair and glioblastoma progression. | Cell Commun Signal | 2026 | 42351183 | PubTator, text mining | PubMed |
| Designing and molecular docking analysis of newly acetazolamide derived compounds integrating 4-oxothiazolidine group as possible carbonic anhydrase deactivators. | Wiad Lek | 2026 | 42263148 | PubTator, text mining | PubMed |
| Association of CA12 with calcification in ER+/HER-2 negative breast cancer. | Discov Oncol | 2026 | 42142233 | PubTator, text mining | PubMed |
| Carbonic Anhydrase Inhibitors in Oncology. | Subcell Biochem | 2026 | 42062763 | PubTator, text mining | PubMed |
| Trends in drug discovery for carbonic anhydrases: FDA approvals, clinical trials, molecular functions, and therapeutic potential. | Pharmacol Res | 2026 | 42044781 | PubTator, text mining | PubMed |
| Discovery of a Novel Coumarin/Thiazole Chalcone Hybrid as a Potent Dual Inhibitor of Tubulin and Carbonic Anhydrases IX & XII with Promising Anti-Proliferative Activity. | Molecules | 2026 | 41900018 | PubTator, text mining | PubMed |
| Loss of CA12 drive proliferation and fibrosis in type i congenital pulmonary airway malformation via promoting abnormal activation of SHH signaling. | Cell Commun Signal | 2026 | 41851891 | PubTator, text mining | PubMed |
| Chromones as Nonclassical Inhibitors of Carbonic Anhydrase IX and XII Isoforms: Probing Chromone-Based Derivatives. | Arch Pharm (Weinheim) | 2026 | 41838040 | PubTator, text mining | PubMed |
| Genome-wide DNA methylation changes after 24 hours at high altitude. | Environ Epigenet | 2026 | 41777793 | PubTator, text mining | PubMed |
| Synthesis of Hydrazidoureidobenzensulfonamides Incorporating a Nicotinoyl Tail and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity. | Pharmaceuticals (Basel) | 2026 | 41754830 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/771/papers